BigJuan.... similar numbers to opt*i which is at .13 today, .19 recently. Potential of this Pharma Phase IV stock is Billions in revenue if they get current and to market. Even with that SS we could easily see $/share BEFORE they go to market if we get enough interest AND current. Should this go to market and sales begin, this type of issue could survive a reverse to help move up to a bigger market, but only After sales start and is solid otc first...
Market Data 
Markets 
